NetworkNewsBreaks – GT Biopharma, Inc. (GTBP) Secures $7.1M through Private Placement
GT Biopharma (OTCQB: GTBP) announced on January 23, 2018 that it entered into definitive agreements for a private placement of convertible notes and warrants for total gross proceeds of $7,055,000. The unsecured convertible notes have a face amount of $7,760,508, an initial conversion price of $4.58 and are due July 2018. Additionally, investors also received warrants to purchase approximately 1,694,440 shares of the company’s common stock at an initial exercise price of $4.58 per share. GT Biopharma intends to use its proceeds from the private placement toward advancing its immuno-oncology programs, progressing its neurology pipeline and for general corporate purposes.…







